title: Auxiliary liver transplantation and bioartificial bridging procedures in treatment of acute liver failure.
abstract: The aim of this review is to discuss the place of auxiliary liver transplantation (ALT) and other cellular based bridging procedures such as hepatocyte transplantation, ex vivo liver perfusion, and bioartificial livers, in the treatment of acute liver failure, vis à vis conventional orthotopic liver transplantation. Hepacocyte transplantation, and ex vivo pig or human liver perfusion are still experimental procedures. Bioartificial livers using human tumoral hepatocytes or porcine hepatocytes have been used in clinical situations as a bridge to transplantation, i.e. to gain the time required to find a high-quality graft for conventional or auxiliary liver transplantation. None of these techniques have yet proved capable of keeping a patient alive long enough for the native liver to recover. Conversely, ALT has been shown to be effective in the treatment of acute liver failure and now appears to be a satisfactory bridging procedure pending native liver (NL) regeneration. We report personal experience of 18 ALT procedures performed in 17 patients between October 1992 and December 1999. The ALT procedure was indicated when patients met criteria for conventional transplantation; it was ultimately selected when a fresh frozen biopsy of the NL did no show any fibrosis. Six patients died within the first 2 postoperative months. The remaining 11 patients are alive, with a follow-up ranging from 2 to 7 years. Regeneration of the NL occurred in 11 of the 17 patients (65%) and in 8 of the 11 survivors (72%), 6 of whom have permanently stopped immunosuppressive therapy. We conclude that liver failure should no longer be handled outside centers where all types of transplantation can be offered, and where innovative therapies such as hepatocyte transplantation and extracorporeal liver-assist devices are being developed and evaluated.
authors.affiliation: Département de Chirurgie Viscérale, Hôpital Universitaire Pontchaillou, 1 rue Henri Le Guilloux, 35033 Rennes, France. boudjema@chu-rennes.fr
authors.forename: Karim
authors.initials: K
authors.lastname: Boudjema
authors.forename: Philippe
authors.initials: P
authors.lastname: Bachellier
authors.forename: Philippe
authors.initials: P
authors.lastname: Wolf
authors.forename: Jean-Daniel
authors.initials: JD
authors.lastname: Tempé
authors.forename: Daniel
authors.initials: D
authors.lastname: Jaeck
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D005260:Female; D022781:Hepatocytes / Q000637:transplantation*; D006801:Humans; D007223:Infant; D008102:Liver Circulation; D017114:Liver Failure, Acute / Q000601:surgery*; D016031:Liver Transplantation / Q000379:methods*; D019164:Liver, Artificial; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D011183:Postoperative Complications